FDA Guidance for Industry: Considerations for Complying With 21 CFR 211.110
Title:
FDA Guidance for Industry: Considerations for Complying With 21 CFR 211.110
Origin/Publisher:
FDA
Content:
This guidance, when finalized, will describe considerations for complying with the requirements in 21 CFR 211.110 to ensure batch uniformity and drug product integrity